Home
|Insights
|"U.S. Healthcare Reform: What's in it for Biosimilars?" European Generics Medicines Association's 8th Annual Symposium on Biosimilars, London

PDF Link

"U.S. Healthcare Reform: What's in it for Biosimilars?" European Generics Medicines Association's 8th Annual Symposium on Biosimilars, London

Speaking Engagement | 09.09.10

Contacts

Keith J. Harrison
Partner
He/Him/His
- Washington, D.C.
  - D | +1.202.624.2560
a2hhcnJpc29uQGNyb3dlbGwuY29t

Insights

Speaking Engagement | 09.30.26

"A New Era for Women’s Health: Aligning Capital and Policy in Women’s Health Innovation, A Panel with Investors and Companies at the Forefront of Women’s Health," NewYorkBIO Innovation Summit

Speaking Engagement | 09.29.26
"Lawyers-as-Experts Panel #1," Lexangle on Experts 2026
Speaking Engagement | 09.29.26
"Regulatory Uncertainty? No Excuse: Proactive Product Safety Strategies for a Borderless Global Marketplace," ICPHSO 2026 International Symposium
Speaking Engagement | 09.29.26
"The Future of Pricing, Personalization & Consumer Protection," California Retailers' Association 2026 California Retail Policy & Law Conference

View All Insights

Subscribe

to the latest insights from our team